4//SEC Filing
Rankin Aubrey 4
Accession 0001479290-20-000082
CIK 0001479290other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 7:57 PM ET
Size
13.5 KB
Accession
0001479290-20-000082
Insider Transaction Report
Form 4
Rankin Aubrey
DirectorPresident, Innovation & Tech
Transactions
- Award
Common Stock
2020-07-23+610,041→ 610,041 total - Award
Employee Stock Option (Right to Buy)
2020-07-23$2.54/sh+8,867$22,522→ 8,867 totalExercise: $2.54Exp: 2029-12-19→ Common Stock (8,867 underlying) - Award
Employee Stock Option (Right to Buy)
2020-07-23$2.54/sh+44,828$113,863→ 44,828 totalExercise: $2.54Exp: 2029-05-13→ Common Stock (44,828 underlying) - Award
Common Stock
2020-07-23+57,251→ 667,292 total
Holdings
- 174,302(indirect: By Trust)
Common Stock
- 87,151(indirect: By Foundation)
Common Stock
Footnotes (6)
- [F1]On July 23, 2020, the Issuer completed acquisition (the "Merger") of Hint, Inc ("HintMD"), pursuant to that certain Agreement and Plan of Merger, dated as of May 18, 2020, by and among the Issuer, Heart Merger Sub, Inc., direct wholly-owned subsidiary of the Issuer, HintMD, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by Mr. Rankin in HintMD were automatically cancelled and converted into the right to receive shares of common stock of the Issuer.
- [F2]The Shares subject to the Restricted Stock award vest as follows: 25% on the first anniversary of the vesting commencement date of August 15, 2020, 25% on the second anniversary of the vesting commencement date of August 15, 2020, and 50% on the third anniversary of the vesting commencement date of August 15, 2020, subject to Mr. Rankin's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) as of each such vesting date.
- [F3]These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.
- [F4]These shares are held by the Rankin Family Foundation. Mr. Rankin is a Trustee of the Rankin Family Foundation.
- [F5]The Option shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years beginning from May 1, 2019, subject to Mr. Rankin's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan (the "Plan")) as of each such vesting date.
- [F6]The Option vests in accordance to the following schedule: 25% on the first anniversary of the vesting commencement date of January 1, 2020, and 1/48th vesting each month thereafter for the remaining three years, subject to Mr. Rankin's Continuous Service (as defined in the Plan) as of such date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001818576
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 7:57 PM ET
- Size
- 13.5 KB